Healthcare distributor strengthens renewable energy initiatives and offsets, targeting zero reported Scope 1 and 2 emissions by 2027
The Australian and New Zealand leading healthcare distributor and animal care, EBOS Group Limited (ASX/NZX: EBO), has published its FY2025 Climate Statement detailing its progress on its transition strategy. The update will cover the period between 1 July 2024 and 30 June 2025 and will include information about greenhouse gas (GHG) emissions, transition endeavors, and risk-related to climate.
EBOS is disclosed to comply with Aotearoa New Zealand Climate Standards as its operations are in more than 133 locations in both Australia and New Zealand. The company emphasized the progress in the purchase of renewable energy, reforestation cooperation, and carbon offsets and admitted the difficulty in decreasing Scope 3 emissions.
Key Findings
EBOS has recorded the steady overall level of emissions, which has been reinforced by energy efficiency programs and uptake of renewable energy.
Highlights from FY2025 results:
- Scope 1 GHG emissions: 3,343 tCO 2, entirely offset by 3,343 Australian Carbon credit Units (ACCUs ).
- Scope 2 (market based) emissions: decreased to 15311 tCO 2e, compared to 16354 in FY2024.
- Net Scope 1 and 2 emissions: Zero, post offsets.
- Energy efficiency: A 12.3% decrease in grid electricity intensity was realized since FY2021, which is less than the 15% objective.
- Reforestation project: EBOS has purchased 94 hectares of native trees to plant in South Gippsland, Victoria, in FY2026 .
- Greenfleet partnership: It is predicted to sequester 20,088 tCO 2 e of FY2025 donations (10 per cent annual growth).
Economic and Strategy Advantages
The company underscored that the renewable energy and offsets investments will make EBOS achieve its goal of zero reported Scope 1 and 2 emissions by 2027.
The chair Elizabeth Coutts remarked:
Our FY2025 Climate Statement shows an advancement towards the reduction of operational emissions and biodiversity by planting new trees. Although these issues are still there, we strive to achieve sustainable growth and investor satisfaction.
EBOS emphasized that its strategy aligns economically with healthcare supply resilience as demand to have green supply chains grows in Australia and New Zealand.
Resource and Exploration News.
The transition plan of EBOS consists of:
- Planning to increase renewable electricity purchases in Australia, and development of solar arrays is going on.
- Eliminating fossil-fuel powered equipment, such as swapping forklift fleets with electric ones.
- Maintaining the offset dependence and moving to in-house project investment in order to limit exposure to the carbon credit market fluctuations.
Although Scope 3 emissions are not reported yet, EBOS stated that it is working on defining the limits of reporting, especially in the third-party freight and supply chains.
Market and Strategic Context.
The disclosure of the climate is in the backdrop of increasing demands on supply chains to decarbonise globally. The fact that EBOS has concentrated more Scope 2 emissions in Australia, with more than 80 percent of emission related to buildings in the country, highlights the necessity of renewable infrastructure.
The future of the industry predicts that the need of sustainable logistics will grow in the sphere of healthcare, animal care, and pharmaceutical distribution. The proactive move toward EBOS would make the company more competitive in the long-term, in the face of its global counterparts especially where carbon prices and ESG reporting are increasing.
Investor Outlook
EBOS shares (ASX/NZX: EBO) closed at 26.36, 2.25% up on the day, with a market capitalisation of 5.28 billion. To date, the stock has been performing between a range of 23.90 to 27.10, and this shows a strong investor confidence in spite of the general market turbulence.
EBOS Group Limited (ASX/NZX: EBO)
According to analysts, the climate efforts of EBOS are incremental, but enhance its resilience to regulatory and operational risks associated with extreme weather and carbon pricing.
Final Thoughts
The FY2025 Climate Statement of EBOS is another step forward to achieving its 2027 zero Scope 1 and 2 emissions target. With renewable energy growth, offset plans and tree planting initiatives, the group is aligning their operations to the expectations of investors and global climate policies.
With the growing climate and regulatory challenges in the healthcare and logistics sector, the strategy of EBOS brings out the issues and opportunities associated with decarbonising the distribution networks in large scale.
Frequently Asked Questions (FAQs)
- What is EBOS Group’s FY2025 Climate Statement?
EBOS Group’s FY2025 Climate Statement is its second mandatory climate disclosure, outlining emissions performance, risks, and sustainability initiatives for the year ended 30 June 2025. - What emissions did EBOS report for FY2025?
EBOS reported Scope 1 emissions of 3,343 tCO₂e, fully offset through Australian Carbon Credit Units, and Scope 2 market-based emissions of 15,311 tCO₂e. Net Scope 1 and 2 emissions were zero after offsets. - What are EBOS’ key climate targets?
EBOS aims to achieve zero reported Scope 1 and 2 emissions by 2027, reduce grid electricity intensity by 15% against a FY2021 baseline, and expand renewable energy generation through solar projects. - What progress has EBOS made on renewable energy?
EBOS has completed a 500kW solar array at its Parkes facility in New South Wales and is developing a 5MW ground-mounted solar project, scheduled for completion in FY2027. - What role does reforestation play in EBOS’ climate strategy?
In FY2025, EBOS purchased 94 hectares in South Gippsland, Victoria, for reforestation with Greenfleet. The project aims to enhance biodiversity and offset future emissions. - How does EBOS manage climate-related risks?
EBOS uses scenario analysis, insurer assessments, and its ESG Steering Committee to evaluate physical and transitional risks, including supply chain disruption, extreme weather, and regulatory changes. - How has EBOS’ share price performed in 2025?
As of 1 October 2025, EBOS shares closed at $26.36, with a market capitalisation of $5.28 billion. The stock has traded between $23.90 and $27.10 year-to-date.
